Tau hyperphosphorylation is an outstanding pathological characteristic of neurodegenerative diseases such as Alzheimer's disease (AD), frontotemporal dementia (FTD), and progressive supranuclear palsy (PSP). This evidence concerns the gene MAPT and Alzheimer disease.